Journal of Clinical Oncology · 2005 · 31 citations · 0 references
PharmacyOncologyPharmacologyCancer Drug Toxicity ManagementImmunotherapyTumor ImmunologyCancer ImmunotherapyImmune Checkpoint InhibitorsImmunotherapy For Skin CancerImmunotherapy SafetyMelanoma PharmacotherapyToxicity ManagementImmunotherapy TrialsMelanoma ImmunotherapyRecommended Phase Ii DoseSafety Profile CharacterizationSafety Tolerability AssessmentSingle-dose TherapySingle-dose ToxicityTotal Dose
7524